Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: Inhibition of metastatic tumor growth in severe combined immunodeficiency mice

American Journal of Pathology

Volumn 177, Issue 6, 2010, Pages 3169-3179

  Stearns, Mark E ^a   Amatangelo, Michael D ^a   Varma, Devika ^a   Sell, Chris ^a   Goodyear, Shaun M ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; EPIGALLOCATECHIN GALLATE; HERMES ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SENSITIZATION; HUMAN; HUMAN CELL; LOW DRUG DOSE; MALE; METASTASIS INHIBITION; MITOCHONDRIAL MEMBRANE POTENTIAL; MONOTHERAPY; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN CLEAVAGE; SCID MOUSE; SURVIVAL RATE;

EID: 78650217504     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100330     Document Type: Article

References (40)

1. Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet RA, Boone CW, Covey JM, Doody LA, Omenn GS, Greenwald P, Hong WK, Parkinson DR, Bagheri D, Baxter GT, Blunden M, Doeltz MK, Eisenhauer KM, Johnson K, Knapp GG, Longfellow DG, Malone WF, Nayfield SG, Seifried HE, Swall LM, Sigman CC: Clinical development plan: tea extracts, green tea polyphenols, and epigallocatechin gallate. J Cell Biochem Suppl 1996, 26:236-257
2. Bushman JL: Green tea and cancer in humans: a review of the literature. Nutr Cancer 1998, 31:151-159
3. Higdon JV, Frei B: Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003, 43:89-143
4. Ahn WS, Yoo J, Huh SW, Kim CK, Lee JM, Namkoong SE, Bae SM, Lee IP: Protective effects of green tea extracts (Polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev 2003, 12:383-390
5. Nelson WG: Agents in development for prostate cancer prevention. Expert Opin Invest Drugs 2004, 13:1541-1554 (Pubitemid 39625140)
6. Jian L, Xie LP, Lee AH, Binns CW: Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer 2004, 108:130-135
7. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H: Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 2001, 98:10350-10355
8. Suttie A, Nyska A, Haseman JK, Moser GJ, Hackett TR, Goldsworthy TL: A grading scheme for the assessment of proliferative lesions of the mouse prostate in the TRAMP model. Toxicol Pathol 2003, 31:31-38 (Pubitemid 36169419)
9. Shannon R, Kinney M, Zhang W, Pascual M, Greally JM, Gillard BM, Karasik E, Foster BA, Karpf AR. Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate. Cancer Prevention Research 2009, 2:1065-1072
10. Nakagawa K, Miyazawa T: Chemiluminescence-high-performance liquid chromatographic determination of tea catechin, (-)-epigallocatechin 3-gallate, at picomole levels in rat and human plasma. Anal Biochem 1997, 248:41-49
11. Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, Sesterhenn IA, McLeod DG, Srivastava S, Rhim JS: Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Cancer Res 2007, 67:3153-3161
12. Goodyear SM, Amatangelo MD, Stearns ME: Dysplasia of human prostate CD133hi SPs in NOD-SCIDs is blocked by c-myc anti-sense. The Prostate 2009, 69:689-698
13. Goodyear SM, Amatangelo MD, Stearns ME. Role of tumor initiating cells in prostate cancer. Trends in Cancer Res 2009, 5:71-88
14. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63
15. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual, 3rd ed. Woodbury, New York, Cold Spring Harbor Laboratory Press, 2003, 1:2.82-2.108
16. Stearns ME, Jason B, Zhang H, Francis MK: Sell, C Insulin-like growth factor 1 (IGF-1) induction of vascular endothelial growth factor (VEGF) is dependent upon activated. Ras Cancer Res 2005, 65:2085-2088
17. Sharma V, Joseph C, Ghosh S, Agarwal A, Mishra MK, Sen E: Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol Cancer Ther 2007, 6:2544-2553 (Pubitemid 47480420)
18. Klarmann GJ, Hurt EM, Mathews LA, Zhang XH, Duhagon MA, Mistree T, Thomas SB, Farrar WL: Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Expl Metastsis 2009, 26:433-446
19. Goodyear SM, Kheyfets SB, Garcia FU, Stearns ME: Role of the VEGFR3/VEGFD receptor axis in TGFβ1 activation of primary prostate cell lines. The Prostate 2009, 69:982-990
20. Mukhtar T, Wang Z, Katiyer SK, Agarwal R: Tea components: antimutagenic and anticarcinogenic effects. Prev Med 1992, 21:351-360
21. Stearns ME, Wang M, Stearns M: IL-10 blocks collagen IV invasion by "invasion stimulating factor" activated PC-3 ML cells: upregulation of TIMP-1 expression. Oncol Res 1995, 7:157-163
22. Katiyar SK, Agarwal R, Mukhtar H: Inhibition of spontaneous and photo-enhanced lipid peroxidation in mouse epidermal microsomes by epicatechin derivatives from green tea. Cancer Lett 1994, 79:61-66
23. Nishida H, Omori M, Fukutomi Y, Ninomiya M, Nishiwaki S, Suganuma M, Moriwaki H, Muto Y: Inhibitory effects of (-)-epigallocatechin gallate on spontaneous hepatoma in C3H/HeNCrj mice and human hepatoma-derived PLC/PRF/5 cells. Jpn J Cancer Res 1994, 85:221-225
24. Sagesaka-Mitane Y, Sugiura T, Miwa Y, Yamaguchi K, Kyuki K: Effect of tea-leaf saponin on blood pressure of spontaneously hypertensive rats. Yakugaku Zasshi 1996, 116:388-395 (Pubitemid 26191022)
25. Sano M, Takahashi Y, Yoshino K, Shimoi K, Nakamura Y, Tomita I, Oguni I, Konomoto H: Effect of tea (Camellia sinensis L.) on lipid peroxidation in rat liver and kidney: a comparison of green and black tea feeding. Biol Pharm Bull 1995, 18:1006-1008
26. Nagata T: Studies on useful components of tea in leaves of the Genus Camellia. Bull Nat Res Inst Tea 1986, 21:60-120
27. Sadzuka Y, Sugiyama T, Sonobe T: Efficacies of tea components on Dox induced antitumor activity and reversal of multidrug resistance. Toxicology Letters 2000, 114:155-162
28. Sadzuka Y, Sugiyama T, Hirota S: Modulation of cancer chemotherapy by green tea. Clin Cancer Res 1998, 4:153-156
29. Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki, H. Synergistic effects of (-)-epigallocatechin gallate with (-)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res 1999, 59:44-47 (Pubitemid 29062952)
30. Landis-Piwowar KR, Huo C, Chen D, Milacic V, Shi G, Chan TH, Dou QP: A novel PEGCG of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Cancer Res 2007, 67:4303-4310
31. Collins AT, Habib FK, Maitland NJ, Neal DE: Identification and isolation of human prostate epithelial stem cells based on α2β1-integrin expression J Cell Sci 2001, 114:3865-3872
32. Schmelz M, Moll R, Hesse U, Prasad AR, Gandolfi JA, Hasan SR, Bartholdi M, Cress AE: Identification of a stem cell candidate in the normal human prostate gland. Eur J Cell Biol 2005, 84:341-354
33. McKeon F: p63 and the epithelial stem cell: more than status quo? Genes Development 2004, 18:465-469
34. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT: CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 2004, 117:3539-3545 (Pubitemid 39206394)
35. Leong KG, Wang BE, Johnson L, Gao WQ: Generation of a prostate from a single adult stem cell. Nature 2008, 456:804-808
36. Sotomayor P, Godoy A, Smith GJ, Huss WJ: Oct4A is expressed by a subpopulation of prostate neuroendocrine cells. Prostate 2009, 69:401-410
37. Vander Griend V, Karthaus DJ, Dalrymple WLS, Meeker A, DeMarzo AM, Isaacs JT: The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells. Cancer Res 2008, 68:9703-9711
38. Xin L, Lawson DA, Witte ON: The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 2005, 102:6942-6947 (Pubitemid 40675421)
39. Sugiyama T, Sadzuka Y: Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma. Cancer Lett 1998, 133:19-26
40. Wei C, Guomin W, Yujun L, Ruizhe Q.: Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line? Cancer Biol Ther 2007, 6:763-768